JP Morgan Maintains Overweight on CG Oncology, Raises Price Target to $113

Benzinga · 1d ago
JP Morgan analyst Brian Cheng maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $96 to $113.